Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study.

Malin SundOsvaldo Fonseca-RodríguezAndreas JosefssonKarin WelenAnne-Marie Fors Connolly

Published in: BMJ open (2022)

Oestrogen supplementation in postmenopausal women is associated with a decreased risk of dying from COVID-19 in this nationwide cohort study. These findings are limited by the retrospective and non-randomised design. Further randomised intervention trials are warranted.

Keyphrases

postmenopausal women
coronavirus disease
bone mineral density
sars cov
clinical trial
open label
double blind
study protocol
randomized controlled trial
cross sectional
placebo controlled
palliative care
respiratory syndrome coronavirus